Alison A. Bertuch

4.9k citations

77 papers · 2.2k indexed · h-index 27

Impact in

Aging top 1%
- Genetics, Aging, and Longevity in Model Organisms
Physiology top 2%
- Telomeres, Telomerase, and Senescence

Papers in

Aging 10
- Genetics, Aging, and Longevity in Model Organisms 10
Hematology 16
- Acute Myeloid Leukemia Research 11

Co-authors: Sharon A. Savage Victoria Lundblad Albert Ribes‐Zamora M. Monica Gramatges Caroline Kannengiesser Patrick Revy Ivana Mihalek Christopher L. Williams
Journals: Blood (9 papers)Pediatric Blood & Cancer (7 papers)Genetics (5 papers)Blood Advances (2 papers)Journal of Biological Chemistry (2 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Alison A. Bertuch

75 papers receiving 2.2k citations

Peers

Countries citing papers authored by Alison A. Bertuch

Since Specialization

Citations

This map shows the geographic impact of Alison A. Bertuch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison A. Bertuch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison A. Bertuch more than expected).

Fields of papers citing papers by Alison A. Bertuch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison A. Bertuch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison A. Bertuch. The network helps show where Alison A. Bertuch may publish in the future.

Co-authors

The 25 scholars most cited alongside Alison A. Bertuch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alison A. Bertuch Line = papers co-authored together Alison A. Bertuch links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic Malignancy Clinical Cancer Research ·Luke Maese, Marcin W. Włodarski, Alias Afzanizam, Alison A. Bertuch, Gaëlle Bougeard, Vivian Y. Chang, Lucy A. Godley, Payal P. Khincha, Roland P. Kuiper, Harry Lesmana, Rose B. McGee, Lisa J. McReynolds, Gépkocsironcsok Varga, Sharon E. Plon, Sharon A. Savage, Sarah Scollon, Hamish S. Scott, Michael F. Walsh, Kim E. Nichols, Christopher C. Porter	2024	3
2	The germline p53 activation syndrome: A new patient further refines the clinical phenotype American Journal of Medical Genetics Part A ·Runjun D. Kumar, Mustafa Tosur, Seema R. Lalani, Donald H. Mahoney, Alison A. Bertuch	2022	3
3	Identification and characterization of novel ACD variants: modulation of TPP1 protein level offsets the impact of germline loss-of-function variants on telomere length Molecular Case Studies ·Victória Pereira dos Anjos, Christopher L. Williams, Pengfei Liu, Alison A. Bertuch	2021	7
4	Expansion of the clinical phenotype of GALE deficiency American Journal of Medical Genetics Part A ·Joanna Page Andros, Nichole Owen, Lisa Forbes Satter, Susan E. Kirk, Donald H. Mahoney, Alison A. Bertuch, Fernando Scaglia	2021	7
5	Severe therapy‐related toxicities after treatment for Hodgkin lymphoma due to a pathogenic TERT variant and shortened telomeres Pediatric Blood & Cancer ·Debasis Mallik, Alison A. Bertuch, Courtney D. DiNardo, Sharon E. Plon, Olive S. Eckstein	2019	2
6	From incomplete penetrance with normal telomere length to severe disease and telomere shortening in a family with monoallelic and biallelic PARN pathogenic variants Human Mutation ·Muhammad Randi Satrio, Antonio Amorim Silva Filho, 嘉裕西村, Vijay Rai, Penelope E. Bonnen, Geraldine Aubert, Sherri Birchansky, Anders Virtanen, Alison A. Bertuch	2019	15
7	Somatic mutations in children with GATA2-associated myelodysplastic syndrome who lack other features of GATA2 deficiency Blood Advances ·Kevin E. Fisher, Amy P. Hsu, Christopher L. Williams, Texter Ec, Cuong Le, M. Tarek Elghetany, Steven M. Holland, Alison A. Bertuch, M. Monica Gramatges	2017	25
8	Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC) Clinical Lymphoma Myeloma & Leukemia ·Courtney D. DiNardo, Sarah A. Bannon, Mark J. Routbort, Anna R. Franklin, Maureen E. Mork, Mary Armanios, Emily M. Mace, Jordan S. Orange, Ruhi Naz Nayyer, Jane E. Churpek, Koichi Takahashi, Jeffrey L. Jorgensen, Guillermo Garcia‐Manero, Steve Kornblau, Alison A. Bertuch, Hannah Cheung, Kapil N. Bhalla, P. Andrew Futreal, Lucy A. Godley, Keyur P. Patel	2016	66
9	TRF2 Interaction with Ku Heterotetramerization Interface Gives Insight into c-NHEJ Prevention at Human Telomeres Cell Reports ·Albert Ribes‐Zamora, HELOIZA ARANTES SILVA, Ivana Mihalek, Christopher L. Williams, Alison A. Bertuch	2013	56
10	Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromes Leukemia & lymphoma ·Jane E. Churpek, Liwei Duan, Sara Sporiš, Kenan Onel, Olufunmilayo I. Olopade, April Sorrell, Carolyn Owen, Alison A. Bertuch, Lucy A. Godley	2012	61
11	Clinical, histopathologic, and genetic features of pediatric primary myelofibrosis—An entity different from adults American Journal of Hematology ·Otto Stuhlman, Andrea M. Sheehan, D. M. Chagadama, Alison A. Bertuch, Mechthild Glunz, C. Renee Webb, Dolores López‐Terrada, Lakshmi Venkateswaran	2012	25
12	A role for heterochromatin protein 1γ at human telomeres Genes & Development ·Sı́lvia Canudas, Benjamin R. Houghtaling, Monica Bhanot, Ghadir Sasa, Sharon A. Savage, Alison A. Bertuch, Susan Smith	2011	81
13	Ku Must Load Directly onto the Chromosome End in Order to Mediate Its Telomeric Functions PLoS Genetics ·Drew Konow, Albert Ribes‐Zamora, HELOIZA ARANTES SILVA, Christopher L. Williams, Svasti Haricharan, Alison A. Bertuch	2011	33
14	The genetics and clinical manifestations of telomere biology disorders Genetics in Medicine ·Sharon A. Savage, Alison A. Bertuch	2010	162
15	Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O 6-methylguanine-DNA methyltransferase activity Molecular Cancer Therapeutics ·Terzah M. Horton, Anshul Saxena, Debananda Pati, Linna Zhang, M. Eileen Dolan, Albert Ribes‐Zamora, Alison A. Bertuch, Susan M. Blaney, 杨孝业, Madhuri Hegde, Stacey L. Berg	2009	67
16	Infantile fibrosarcoma: Clinical and histologic responses to cytotoxic chemotherapy Pediatric Blood & Cancer ·Heidi V. Russell, John Hicks, Alison A. Bertuch, Murali Chintagumpala	2009	27
17	Changes Mimicking New Leptomeningeal Disease After Intensity-Modulated Radiotherapy for Medulloblastoma International Journal of Radiation OncologyBiologyPhysics ·Jodi A. Muscal, Jeremy Jones, Arnold C. Paulino, Alison A. Bertuch, Jack Su, Shiao Y. Woo, Donald H. Mahoney, Murali Chintagumpala	2008	10
18	Distinct faces of the Ku heterodimer mediate DNA repair and telomeric functions Nature Structural & Molecular Biology ·Albert Ribes‐Zamora, Ivana Mihalek, Olivier Lichtarge, Alison A. Bertuch	2007	84
19	The Way to the End Matters: The Role of Telomerase in Tumor Progression Cell Cycle ·Alison A. Bertuch, Kathleen M. Buckley, Victoria Lundblad	2003	4
20	Telomeres: The Molecular Events Driving End-To-End Fusions Current Biology ·Alison A. Bertuch	2002	8

About Alison A. Bertuch

Alison A. Bertuch is a scholar working on Aging, Hematology, Physiology, Molecular Biology and Genetics, having authored 77 papers that have together received 2.2k indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (35 papers), DNA Repair Mechanisms (25 papers), CRISPR and Genetic Engineering (11 papers), Acute Myeloid Leukemia Research (11 papers), Genetics, Aging, and Longevity in Model Organisms (10 papers), Blood disorders and treatments (8 papers), Muscle Physiology and Disorders (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Aging (190 citations), Physiology (989 citations), Hematology (343 citations), Molecular Biology (1.4k citations) and Genetics (206 citations). Alison A. Bertuch has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Sharon A. Savage, Victoria Lundblad, Albert Ribes‐Zamora, M. Monica Gramatges, Caroline Kannengiesser, Patrick Revy, Ivana Mihalek, Christopher L. Williams, Ghadir Sasa and Olivier Lichtarge. Their work appears in journals such as Blood, Pediatric Blood & Cancer, Genetics, Blood Advances and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact